BANX (ArrowMark Financial) Research & Development: $0.00 Mil (TTM As of Dec. 2025)


BANX ArrowMark Financial Corp BANX
67 GF Score
Price $19.55
GF Value $22.20
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is ArrowMark Financial Research & Development?

ArrowMark Financial BANX +0.05% 67 Research & Development is $0.00 Mil as of Dec. 2025. GuruFocus rates BANX with a GF Score™ of 67/100 and a GF Value™ of $22.20 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. ArrowMark Financial's Research & Development for the six months ended in Dec. 2025 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00 Mil.

ArrowMark Financial  (NAS:BANX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

ArrowMark Financial Research & Development Related Terms

ArrowMark Financial Research & Development Historical Data

* Premium members only.

The historical data trend for ArrowMark Financial's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ArrowMark Financial Research & Development Chart

ArrowMark Financial Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ArrowMark Financial Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BANX
67GF Score
ArrowMark Financial Corp BANX
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ArrowMark Financial Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
ArrowMark Financial (BANX) has a Research & Development of $0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on ArrowMark Financial and its competitors.
Is ArrowMark Financial's Research & Development too high?
ArrowMark Financial's current Research & Development is $0.00 Mil. Overall, ArrowMark Financial has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ArrowMark Financial's Research & Development compare to WHG and WIA?
ArrowMark Financial's Research & Development of $0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on ArrowMark Financial and its competitors. ArrowMark Financial's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ArrowMark Financial stock overvalued right now?
Based on GuruFocus' analysis, ArrowMark Financial (BANX) is currently considered Modestly Undervalued. The stock's GF Value™ is $22.20, compared to a current price of $19.55 — trading 12% below its estimated fair value. The current Research & Development is $0.00 Mil. ArrowMark Financial's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For ArrowMark Financial (BANX), the current Research & Development is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ArrowMark Financial (BANX) Overvalued in 2026?

Based on GuruFocus' analysis, ArrowMark Financial stock appears to be undervalued. The current stock price of $19.55 is trading 12% below its estimated GF Value™ of $22.20. GuruFocus considers ArrowMark Financial to be Modestly Undervalued.

Key valuation signals for BANX:

  • Research & Development: $0.00 Mil
  • GF Value™: $22.20 vs. price of $19.55 (12% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the BANX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ArrowMark Financial Business Description

Address 100 Fillmore Street, Suite 325, Denver, CO, USA, 80206
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. The Fund's objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.
67GF Score

Get the complete analysis for BANX

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.55
Price
$22.20
GF Value